We are monitoring the impact of COVID-19 on APAC Cervical Cancer Diagnostics And Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Cervical Cancer Diagnostics and Therapeutics Market Research Report - Segmented By Diagnostics Test, Methods, Therapies, End-users & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 774
Pages: 135

APAC Cervical Cancer Diagnostics and Therapeutics Market Size (2022 to 2027)

The Asia-Pacific Cervical Cancer Diagnostics and Therapeutics market was estimated at USD 862.14 Million in 2022. It is projected to reach USD 1164.67 Million by 2027, at a CAGR of 6.2% during the forecast period from 2022 to 2027.

The market is predicted to develop as the adoption of cervical cancer diagnostic tests for the early identification of cervical cancer rises. The growth of the APAC cervical cancer diagnostics and therapeutics market is linked to increased awareness among the general population about the care, prevention, and treatment of cervical cancer, as well as an increase in certain behaviors such as sex with multiple partners and smoking, as well as certain genetic factors and a weak immune system. Awareness campaigns have aided market expansion. For example, the popular government insurance program Medicaid offers cervical cancer screening.

The cancer diagnostics and therapeutics market in the APAC region are further forecasted to grow due to an increase in the incidence and prevalence of various types of cancer, such as breast cancer and lung cancer, over the forecast period. Furthermore, the cancer diagnostics market will profit from a surge in technological advancements that aid in better imaging of cancerous cells, improvements in equipment to diagnose the kind of cancer, and an increase in the efficiency of the results throughout the forecast period.

In addition, during the forecast period, the market is likely to be driven by an increase in diagnostics laboratories in this region. Furthermore, the market's growth is fueled by the rise in R&D investment, an increase in the geriatric population, the introduction of technologically advanced products, and a surge in the launch of new and advanced kits and reagents.

However, the high cost of diagnostic imaging systems and the development of diverse diagnostic techniques for distinct cancer mutations may stymie market expansion. Furthermore, supply chains and manufacturing activities in India, China, the United States, and other countries have been affected due to the lockdown. In contrast, medicine and medical device shipping in Thailand, Indonesia, and Singapore has been hampered. In addition, there is a scarcity of medical care for disorders other than COVID-19 around the world, which has had a negative impact on the cancer diagnostics business. At the same time, limited healthcare staff availability is another aspect that has a negative impact on the cancer diagnostics and therapeutics market in APAC.

This research report on the Asia pacific cervical cancer diagnostics and therapeutics market has been segmented and sub-segmented into the following categories:

By Diagnostics Test:

  • Pap Smear Test
  • HPV Testing
  • Colposcopy
  • Cervical Cancer Biopsy

By Methods:

  • Molecular Method
  • Cytopathological Method
  • Physical Method

By Therapies:

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Others

By End-users:

  • Hospitals
  • Laboratories
  • Independent Physicians
  • Clinics
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The fastest-growing market for cervical cancer diagnostic tests is Asia-Pacific, attributed to rising cervical cancer prevalence in developing nations such as China, India, Malaysia, Japan, South Korea, and Australia. Due to the high prevalence of cervical cancer, Asia-Pacific is predicted to rise rapidly during the forecast period. Cervical cancer has a high prevalence rate among the population, ascribed to factors such as a lack of understanding about hygiene and precaution. The high prevalence of cervical cancer in the Asia Pacific, combined with a more robust government emphasis on screening and advancements in cervical cancer detection, is expected to promote market growth. In addition, during the forecast period, there will be a significant increase in emphasis on health and safety laws and a rise in the popularity of yoga and other health-related activities.

KEY MARKET PLAYERS:

Companies playing a notable role in the APAC cervical cancer diagnostics and therapeutics market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, and Volition Rx.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By diagnostics test                 

                             5.1.1 Pap smear test     

                             5.1.2 HPV testing           

                             5.1.3 Colposcopy           

                             5.1.4 Cervical cancer biopsy      

              5.2 By methods                            

                             5.2.1 Molecular method             

                             5.2.2 Cytopathological method 

                             5.2.3 Physical method  

              5.3 By therapies                           

                             5.3.1 Surgery    

                             5.3.2 Radiation therapy

                             5.3.3 Chemotherapy     

                             5.3.4 Other therapies   

              5.4 By end-users                          

                             5.4.1 Hospitals 

                             5.4.2 Laboratories         

                             5.4.3 Independent physicians   

                             5.4.4 Clinics      

                             5.4.5 Other end-users  

6. Geographical Analysis                                         

              6.3 Asia-Pacific               

                             6.1 Introduction             

                             6.2 China           

                             6.3 India            

                             6.4 Japan           

                             6.5 South Korea             

7. Pipeline Product Analysis                                    

              7.1 Overview                  

              7.2 Pipeline Development Landscape                   

              7.3 Molecular Targets in the Pipeline                   

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target    

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                            8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 Abbott Diagnostics                

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Alere                          

              9.3 Beckman Coulter                   

              9.4 Clinical Genomics                  

              9.5 Companion Dx                       

              9.6 EDP Biotech              

              9.7 Epigenomics AG                     

              9.8 Exact Sciences                        

              9.9 Fujirebio                    

              9.10 Genomic Tree                      

              9.11 Metabiomics                        

              9.12 Siemens Healthcare                          

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures  

  1. Asia-Pacific Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Cervical Cancer Pap smear test Market By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Cervical Cancer HPV testing Market By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Cervical Cancer Colposcopy Market By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Cervical cancer biopsy Market By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  8. Asia-Pacific Molecular method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Cytopathological method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific Physical method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Surgery Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  13. Asia-Pacific Radiation therapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  14. Asia-Pacific Chemotherapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  15. Asia-Pacific Other therapies Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  16. Asia-Pacific Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)
  17. Asia-Pacific Hospitals Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  18. Asia-Pacific Laboratories Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  19. Asia-Pacific Independent physicians Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  20. Asia-Pacific Clinics Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2022 - 2027 (USD Million)
  21. Asia-Pacific Other end-users Market By Region, From 2022 - 2027 (USD Million)
  22. China Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  23. China Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  24. China Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  25. China Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)
  26. India Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  27. India Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  28. India Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  29. India Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)
  30. Japan Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  31. Japan Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  32. Japan Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  33. Japan Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)
  34. South Korea Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  35. South Korea Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  36. South Korea Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  37. South Korea Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)
  38. Australia Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2022 - 2027 (USD Million)
  39. Australia Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2022 - 2027 (USD Million)
  40. Australia Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2022 - 2027 (USD Million)
  41. Australia Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample